article thumbnail

How FSP Solutions Support Risk-Based Methodologies and Tech Innovation in Clinical Operations

PPD

A recent white paper from the PPD clinical research business of Thermo Fisher Scientific details how these functions have evolved over the years to the point where multiple outsourcing models are now commonly utilized. Electronic medical records (EMRs), for example, exemplify the evolving role of technology in clinical trials.

article thumbnail

Winning Regulatory Trust: Six Smart Strategies for Emerging Biotechs

PPD

Effective communication with regulatory authorities is critical for small biotech companies, as it is often the key to success in clinical trials. Explore our white paper The post Winning Regulatory Trust: Six Smart Strategies for Emerging Biotechs appeared first on PPD.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Overcome Critical Retention Challenges in Obesity Trials

Fierce BioTech

Overcome Critical Retention Challenges in Obesity Trials Ready to transform your obesity trial outcomes? smarcus Thu, 07/17/2025 - 17:29 Ready to transform your obesity trial outcomes? Avacare Clinical Research Network Resource Type Whitepaper avacare_clinical_research_network_logo-250x190.png

Trials 52
article thumbnail

Redefining vaccine trial recruitment

Fierce BioTech

Redefining vaccine trial recruitment Clinical trials are vital for developing safe and effective vaccines, but their success relies on overcoming recruitment challenges and ensuring diverse study cohorts. Discover innovative, data-driven recruitment strategies to ensure diverse, efficient, and high-quality vaccine trials.

Vaccine 52
article thumbnail

Breaking Barriers in Solid Tumor Research: Precision Medicine & Strategic Operations

Conversations in Drug Development Trends

Have you optimized your trial designs to employ precision medicine approaches for your novel solid tumor intervention? Integrate Biomarkers Where Possible Biomarker integration is crucial in solid tumor clinical trials, though more research is needed before fully validated assays become the norm across solid tumor indications.

article thumbnail

The Vital Role of Biomarkers in Neurodegenerative Pathways Early Phase Unit, Worldwide Clinical Trials

Conversations in Drug Development Trends

Early Phase Unit, Worldwide Clinical Trials Neurodegenerative diseases represent a diverse group of progressive disorders characterized by the loss of structure and function of neurons. Integration of fluid biomarkers, imaging, and genetic profiling enhances diagnostic precision and provides valuable tools for clinical trials in ALS.

article thumbnail

The IND Application Process: Strategic Advantages & Enhanced Opportunities

Conversations in Drug Development Trends

This blog highlights some of the key themes discussed in our white paper on the application process, From Concept to Market: The Strategic Role of an IND in Drug DevelopmentMoving Beyond “May Proceed.” Food and Drug Administration (FDA) within 30 days, providing a structured timeline for progressing with clinical trials.